Synthesis of Potent Cyclic Hexapeptide NK-1 Antagonists. Use of a Minilibrary in Transforming a Peptidal Somatostatin Receptor Ligand into an NK-1 Receptor Ligand via a Polyvalent Peptidomimetic
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (13) , 2441-2448
- https://doi.org/10.1021/jm960281e
Abstract
The endogenous peptides somatostatin (SRIF) and substance P comprise very different structures. Although both bind G-protein-coupled receptors, the SRIF receptors (SSTR 1−5) recognize SRIF and related peptides which retain its β-turn such as the potent cyclic hexapeptide SRIF agonist L-363,301 (6a), but not substance P. Conversely the NK-1 receptor binds substance P but not the above ligands. In contrast, the β-d-glucosides 1 and 2, designed to mimic the β-turn of 6a, bind both receptors. This observation led us to attempt the conversion of 6a into the first potent, selective cyclic hexapeptide ligand for the NK-1 receptor. To this end, we combined design with a minilibrary approach. The goal was accomplished with surprising ease, leading to the NK-1 receptor antagonist 9 (IC50 2.0 ± 0.4 nM). This demonstrates that peptidomimetics, incorporating in this case the promiscuous β-d-glucose scaffold, can provide valuable clues about receptor similarities not revealed by their endogenous ligands. In addition, this work suggests that the use of libraries and rational design need not be mutually exclusive approaches to lead discovery.Keywords
This publication has 28 references indexed in Scilit:
- Spiro-piperidine non-peptide neurokinin-1 receptor antagonistsBioorganic & Medicinal Chemistry Letters, 1995
- 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additiveJournal of the American Chemical Society, 1993
- On the origins of the DNA sequence selectivity of mitomycin monoalkylation transformationsJournal of the American Chemical Society, 1992
- Design, synthesis, and binding affinity of a nonpeptide mimic of somatostatinBioorganic & Medicinal Chemistry Letters, 1992
- Activity and Distribution of Binding Sites in Brain of a Nonpeptide Substance P (NK 1 ) Receptor AntagonistScience, 1991
- A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) ReceptorScience, 1991
- Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugarsJournal of Medicinal Chemistry, 1989
- Design and synthesis of somatostatin analogs with topographical properties that lead to highly potent and specific .mu. opioid receptor antagonists with greatly reduced binding at somatostatin receptorsJournal of Medicinal Chemistry, 1988
- A potent cyclic hexapeptide analogue of somatostatinNature, 1981
- Synthesis and antitumor activity of 5-azacytosine arabinosideJournal of Medicinal Chemistry, 1979